๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Psoriasis
Clinical trial register · China

Psoriasis Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hangzhou 6 Shanghai 4 Beijing 4 Guangzhou 2 Shenzhen 2
Narrow the registerReset
Recruitment status
Phase
Site location
Hangzhou6 Shanghai4 Beijing4 Guangzhou2 Shenzhen2
All 19 locations
Target enrolment
to

Psoriasis trials in China

20 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
NCT07724366Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
400
Beijing, Chongqing, Guangzhou, Shenzhen, Nanning, Guiyang, Haikou, Chengde
2026-09-02
Recruiting
Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
NCT07719530Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
60
Guangzhou
2026-08-04
Not yet open
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
NCT07642544Psoriasis, Psoriasis (PsO)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
120
Nanjing
2026-06-01
Not yet open
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
NCT07485764Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis, Overweight , Obesity
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
186
Wuhan
2026-06
Active, closed
Trial of HSK44459 Cream for the Management Plaque Psoriasis
NCT07623486Psoriasis
Haisco Pharmaceutical Group Co., Ltd.
Phase 1/2
180
Hangzhou
2026-05-22
Recruiting
Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
NCT07194200Psoriasis, Lactobacillus Plantarum
Shenzhen People's Hospital
Phase 2
184
Shenzhen
2025-12-15
Active, closed
Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers
NCT07254325Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
114
Shanghai
2025-12-15
Recruiting
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT07265284Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
104
Beijing
2025-12-03
Recruiting
A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
NCT07780929Psoriasis, Psoriasis (PsO)
Xijing Hospital
Not applicable
5
Xi'an
2025-11-17
Not yet open
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07150988Psoriasis
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
150
Hangzhou
2025-09-26
Active, closed
Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability
NCT07321288Psoriasis, Insulin Resistance
Chinese PLA General Hospital
Observational
1,265
Beijing
2025-09-01
Recruiting
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
NCT07033234Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
142
Hangzhou
2025-05-16
By invitation
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
NCT06999941Psoriasis, Eczema, JAK Inhibitor
Xi Tan
Observational
50
Shanghai
2025-04-24
Not yet open
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582Psoriasis
Hansoh BioMedical R&D Company
Phase 2
305
Shanghai
2025-04-09
Not yet open
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06672393Psoriasis
Hansoh BioMedical R&D Company
Phase 3
375
Shanghai
2024-11-04
Not yet open
HPP737 Substance Balance Study in Human
NCT06584058Psoriasis
Newsoara Biopharma Co., Ltd.
Not applicable
8
Suzhou
2024-08-30
Recruiting
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
NCT07532486Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hangzhou
2024-07-10
Recruiting
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
NCT06376474Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd
Phase 1
24
Wuhan
2024-04-28
Recruiting
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NCT05503875Immunoclassification, Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2023-01-01
Recruiting
Chinese Psoriasis Real World Evidence Research
NCT04465838Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Hangzhou, Beijing, Chongqing, Fujian, Gansu, Guangdong, Guangxi, Guizhou
2020-07-08
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/psoriasis

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Psoriasis.

How many Psoriasis trials are recruiting in China?

10 of the 20 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Psoriasis), 20 studies
PhaseStudiesRecruitingShare
Not applicable4320%
Observational4120%
Phase 24220%
Phase 13215%
Phase 33215%
Phase 1/2105%
Phase 4105%

Most active sponsors

Lead sponsors with the most studies (Psoriasis)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine33
Haisco Pharmaceutical Group Co., Ltd.20
Hansoh BioMedical R&D Company20
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.11
Chinese PLA General Hospital10
Ganzhou Hemay Pharmaceutical Co., Ltd11
Guangdong Hengrui Pharmaceutical Co., Ltd11
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.11
Jiangsu Hansoh Pharmaceutical Co., Ltd.11
Newsoara Biopharma Co., Ltd.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.